CASTAGNA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 7.460
EU - Europa 6.367
AS - Asia 4.496
SA - Sud America 633
AF - Africa 144
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.118
Nazione #
US - Stati Uniti d'America 7.313
RU - Federazione Russa 2.665
SG - Singapore 1.772
CN - Cina 1.278
GB - Regno Unito 1.097
IT - Italia 545
DE - Germania 513
BR - Brasile 488
VN - Vietnam 440
SE - Svezia 357
HK - Hong Kong 338
FR - Francia 305
IE - Irlanda 262
FI - Finlandia 257
KR - Corea 136
BD - Bangladesh 101
JP - Giappone 101
CA - Canada 87
IN - India 84
UA - Ucraina 74
AR - Argentina 72
NL - Olanda 54
BE - Belgio 45
TR - Turchia 39
ID - Indonesia 38
ZA - Sudafrica 37
PL - Polonia 34
IQ - Iraq 33
MX - Messico 33
NG - Nigeria 33
ES - Italia 27
LT - Lituania 18
AT - Austria 17
CL - Cile 17
PK - Pakistan 16
VE - Venezuela 16
RO - Romania 14
AU - Australia 12
CH - Svizzera 12
CO - Colombia 12
EG - Egitto 11
IL - Israele 11
KE - Kenya 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
MA - Marocco 10
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
HR - Croazia 8
IR - Iran 8
MY - Malesia 8
DZ - Algeria 7
GR - Grecia 7
JM - Giamaica 7
NP - Nepal 7
PH - Filippine 7
PT - Portogallo 7
TG - Togo 7
TN - Tunisia 7
BJ - Benin 6
UY - Uruguay 6
BG - Bulgaria 5
BO - Bolivia 5
LB - Libano 5
LV - Lettonia 5
PE - Perù 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BH - Bahrain 4
DK - Danimarca 4
EE - Estonia 4
ET - Etiopia 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RS - Serbia 4
CR - Costa Rica 3
HN - Honduras 3
HU - Ungheria 3
NO - Norvegia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GT - Guatemala 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PY - Paraguay 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
Totale 19.091
Città #
Singapore 1.005
Moscow 922
Ashburn 864
Southend 856
Dallas 799
Chandler 741
San Jose 643
Jacksonville 508
Ann Arbor 359
Hong Kong 331
Woodbridge 307
Verona 267
Dublin 262
Houston 219
Beijing 212
New York 208
The Dalles 196
Council Bluffs 159
Ho Chi Minh City 141
Los Angeles 128
Wilmington 119
Munich 117
Lawrence 102
Princeton 102
Tokyo 95
Jinan 85
Hanoi 82
Nanjing 77
Boardman 76
Helsinki 72
Shenyang 70
Santa Clara 61
Buffalo 56
São Paulo 53
Redondo Beach 49
Brussels 45
Hebei 42
Columbus 41
Tianjin 38
Turku 38
Milan 37
Orem 37
Montreal 36
Redmond 35
London 34
Sindelfingen 34
Lancaster 33
Zhengzhou 32
Abuja 31
Changsha 31
Haikou 29
Nanchang 29
Johannesburg 28
Seattle 27
Jiaxing 25
Rio de Janeiro 25
Warsaw 25
Brooklyn 24
Denver 23
Guangzhou 23
Hangzhou 23
Toronto 22
Chennai 21
Falkenstein 21
Frankfurt am Main 21
Jakarta 21
Phoenix 21
Seoul 21
Amsterdam 20
Chicago 20
Dong Ket 20
Haiphong 20
Taiyuan 20
Padova 19
Atlanta 18
Ningbo 18
Taizhou 17
Da Nang 16
Poplar 16
Stockholm 16
Falls Church 15
Norwalk 15
Vienna 15
Hải Dương 14
Manchester 14
Nürnberg 14
San Francisco 14
Shanghai 14
Fuzhou 13
Mumbai 13
Washington 13
Ankara 12
Barnet 12
Buenos Aires 12
Fairfield 12
Mexico City 12
Zurich 12
Baghdad 11
Boston 11
Boydton 11
Totale 11.795
Nome #
Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular Carcinoma 341
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 319
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 250
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 227
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 226
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 218
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 217
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 211
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 209
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 209
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 207
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 206
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 205
Identification of new BMP6 pro-peptide mutations in patients with iron overload 201
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 199
miRNAs purification and analysis from urinary exosomes. 198
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 196
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 196
Immunoaffinity reactors for prion protein qualitative analysis 194
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 194
The proteome: anno Domini 2002 193
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 191
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 190
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 190
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 189
Altered paraoxonase expression in patients with genetic haemochromatosis. 189
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 188
"Exploring the hidden human urinary proteome via ligand library beads" 187
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 185
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 183
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 176
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 175
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 175
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 175
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 175
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 174
“Proteomics approaches for studying chemoresistance in cancer” 173
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 173
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 172
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 172
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 170
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 169
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 169
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 168
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 168
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 168
Monocyte/macrophage proteomics: recent findings and biomedical applications. 167
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 167
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 167
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 166
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 166
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 165
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 164
"Prefractionation of urinary proteins" 164
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 163
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 161
Murine macrophages response to iron 161
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 161
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism 158
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 158
Modern iron replacement therapy: clinical and pathophysiological insights 158
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 158
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 157
Iron metabolism in Murine Macrophages: a proteomic insight. 156
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 151
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 150
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 149
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 149
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 148
Optimizing the purification and analysis of miRNAs from urinary exosomes. 144
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 143
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 142
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 141
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 141
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 140
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 139
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 137
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 136
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 136
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 135
Reduced serum hepcidin levels in patients with chronic hepatitis C 135
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 135
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study 134
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 134
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 131
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 131
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 130
null 129
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 128
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 127
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 127
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 124
Beta-elimination: an unexpected artefact in proteome analysis. 121
Hormone-Dependent Changes in Female Urinary Proteome 121
Circadian exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals 121
Treatment options for anemia in the elderly 117
Urinary extracellular vesicle mRNA analysis of sodium chloride cotransporter in hypertensive patients under different conditions 117
Hepcidin resistance in dysmetabolic iron overload 116
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 113
Reducing protein concentration range of biological samples using solid-phase ligand libraries 113
Totale 16.762
Categoria #
all - tutte 62.892
article - articoli 49.135
book - libri 0
conference - conferenze 12.275
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.482
Totale 125.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022812 62 256 8 63 25 25 7 37 43 18 75 193
2022/20232.027 120 231 167 335 199 474 31 127 261 12 36 34
2023/20241.075 43 88 72 106 117 209 21 69 12 29 189 120
2024/20252.503 125 183 123 427 97 94 128 86 344 160 209 527
2025/20269.103 562 407 887 1.525 2.285 574 854 445 631 527 143 263
Totale 19.281